Post the onset of Covid -19 pandemic and ensuing lockdowns, followed by stock market crash resulted in huge fall in NAVs of most mutual fund schemes. However, Pharma sector gained traction, with need for supply of medicines, support from USFDA in the form of approvals and investors opting for defensive sectors for investment.
Over the last 6 months, Healthcare and Pharma related MFs have dominated the returns basket. Given below is the performance of the 9 existing pharma funds.
It is also important for investors to choose the right mutual funds even from these funds. A detailed understanding at the top 15 stocks held in each mutual fund can help in making the right choices.
Now, with many stocks having run up quite a bit, it is imperative for investors to check the fundamentals and technicals before making the right choices.
Rgds
Gvk.